Yorum: “CD9 AML-M3’ü HLA-DR Negatif M3 Dışı AML’den Ayırt Etmede Çok Faydalı Bir Belirteçtir
Smeeta GajendraLaboratory Oncology Unit, Dr. B.R.A. IRCH, AIIMS, New Delhi, IndiaAnahtar Kelimeler: Akut promiyelositik lösemi, Akış sitometrisi, CD9, CD18
Comment: In Response to “CD9 Is a Very Helpful Marker for Discriminating AML-M3 from HLA-DR-Negative Non-M3 AML”
Smeeta GajendraLaboratory Oncology Unit, Dr. B.R.A. IRCH, AIIMS, New Delhi, IndiaKeywords: Acute promyelocytic leukemia, Flow cytometry, CD9, CD18
Smeeta Gajendra. Comment: In Response to “CD9 Is a Very Helpful Marker for Discriminating AML-M3 from HLA-DR-Negative Non-M3 AML”. . 2020; 37(4): 289-290
Sorumlu Yazar: Smeeta Gajendra, India
Sorumlu Yazar: Smeeta Gajendra, India
| ARAÇLAR |
 Tam Metin PDF Yazdır Alıntıyı İndir RIS EndNote BibTex Medlars Procite Reference Manager E-Postala Paylaş Yazara e-posta gönder
Benzer makaleler Google Scholar |